Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | PAM | P19021 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL790516 | 0.81 | ALDH1A1 (0.46) | ALDH1A1TSHRMAOBCYP2A6IDO1 | |
| SCHEMBL9798232 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRMAOBCYP2A6IDO1 | |
| SCHEMBL902965 | 0.76 | MAOB (0.44) | ALDH1A1MAOBIDO1PAMLMNA | |
| SCHEMBL9217606 | 0.75 | ALDH1A1 (0.36) | ALDH1A1TSHRMAOBCYP2A6IDO1 | |
| SCHEMBL2769032 | 0.75 | ALDH1A1 (0.36) | ALDH1A1TSHRMAOBCYP2A6IDO1 | |
| SCHEMBL93706 | 0.75 | RELA (0.47) | ALDH1A1TSHRMAOBCYP2A6IDO1 | |
| SCHEMBL7054866 | 0.75 | ALDH1A1 (0.36) | ALDH1A1TSHRMAOBCYP2A6IDO1 | |
| SCHEMBL29135403 | 0.75 | IDO1 (0.36) | ALDH1A1TSHRMAOBCYP2A6IDO1 | |
| SCHEMBL3300954 | 0.75 | ALOX15 (0.48) | ALDH1A1PAMMEN1KMT2ALMNA | |
| SCHEMBL28514854 | 0.74 | KMT2A (0.42) | ALDH1A1TSHRMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1093354-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | UNILEVER PLC (GB) | 2001-04-25 | — | — | EP | claimed |
| US-6171582-B1 | TOPICALLY APPLYING TO HUMAN SKIN AN ACTIVE AGENT CAPABLE OF INACTIVATING BODY MALODOUR CAUSING MICROORGANISMS COMPRISING CORYNEBACTERIA. | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2001-01-09 | — | — | US | claimed |
| WO-2000001353-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | UNILEVER PLC (GB) | 2000-01-13 | — | — | WO | claimed |
| CN-115590776-B | Hair growing and thickening essence composition and preparation method and application thereof | 广州禾力生物科技有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-115590776-A | Hair-growing and hair-thickening essence composition and preparation method and application thereof | 广州禾力生物科技有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-114306173-A | Hair loss preventing essence and preparation method thereof | 广州华厦生物制药有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20200062801-A1 | EPIMERIZATION-FREE N TO C SOLID-PHASE PEPTIDE SYNTHESIS | WAYNE STATE UNIVERSITY (US) | 2020-02-27 | — | — | US | disclosed |
| US-20130267680-A1 | TOTAL CHEMICAL SYNTHESIS OF UBIQUITIN, UBIQUITIN MUTANTS AND DERIVATIVES THEREOF | STICHTING HET NEDERLANDS KANKERINSTITUUT | 2013-10-10 | — | — | US | disclosed |
| EP-2616479-A1 | TOTAL CHEMICAL SYNTHESIS OF UBIQUITIN, UBIQUITIN MUTANTS AND DERIVATIVES THEREOF | Stichting Het Nederlands Kanker Instituut (NL) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012036551-A1 | TOTAL CHEMICAL SYNTHESIS OF UBIQUITIN, UBIQUITIN MUTANTS AND DERIVATIVES THEREOF | STICHTING HET NEDERLANDS KANKERINSTITUUT (NL) | 2012-03-22 | — | — | WO | disclosed |
| US-20050244441-A1 | Cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2005-11-03 | — | — | US | disclosed |
| EP-1202628-B1 | NOVEL HYPOXANTHINE AND THIOHYPOXANTHINE COMPOUNDS | EURO CELTIQUE SA (LU) | 2004-10-13 | — | — | EP | disclosed |
| EP-1202628-A4 | NOVEL HYPOXANTHINE AND THIOHYPOXANTHINE COMPOUNDS | EURO CELTIQUE SA (LU) | 2002-10-30 | — | — | EP | disclosed |
| EP-1202628-A1 | NOVEL HYPOXANTHINE AND THIOHYPOXANTHINE COMPOUNDS | Euro-Celtique S.A. (LU) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001011967-A1 | NOVEL HYPOXANTHINE AND THIOHYPOXANTHINE COMPOUNDS | EURO-CELTIQUE S.A. (LU) | 2001-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130267680-A1 | TOTAL CHEMICAL SYNTHESIS OF UBIQUITIN, UBIQUITIN MUTANTS AND DERIVATIVES THEREOF | UBQLN1, UBQLN2, UBE3A | ALDH1A1 2827/4885TSHR 4645/4885MAOB 1301/4885 |
| US-20200062801-A1 | EPIMERIZATION-FREE N TO C SOLID-PHASE PEPTIDE SYNTHESIS | NGLY1, ANPEP, NPPA | ALDH1A1 4830/4885TSHR 2055/4885MAOB 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.